Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma-Reference-Cited by-同舟云学术

Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma

Published:2024-08 Issue:8 Volume:30 Page:793-795
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Maruki Taketomo^ORCID,Nomoto Hidetoshi,Iwamoto Noriko,Yamamoto Kei,Kurokawa Masami,Iwatsuki-Horimoto Kiyoko^ORCID,Yamayoshi Seiya^ORCID,Suzuki Yutaka,Kawaoka Yoshihiro,Ohmagari Norio

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Reference19 articles.

1. The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient—a case study;Sepulcri;Open Forum Infect Dis,2021

2. Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies;Lee;Cancer Discov,2022

3. Extended remdesivir infusion for persistent coronavirus disease 2019 infection;Martinez;Open Forum Infect Dis,2022

4. Successful treatment of persistent symptomatic coronavirus disease 19 infection with extended-duration Nirmatrelvir-Ritonavir among outpatients with hematologic cancer;Liu;Open Forum Infect Dis,2023

5. Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report;Lindahl;Inf Disp,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperimmune Globulins in COVID-19;Current Topics in Microbiology and Immunology;2024